Laboratoires Pierre Fabre is a French multinational pharmaceutical and cosmetics company. The company had a consolidated turnover of 1.978 billion euros in 2012 (including 54% international). It is headquartered in the city of Castres, Midi-Pyrénées, France.
Founded in 1962 by Pierre Fabre (1926-2013), the company is present in over 130 countries. Laboratories Pierre Fabre had approximately 10,000 employees in 2012, 33% of whom are internationally based, while the remaining 6,700 employees were based it France. The company's business activity is focused on research, development, manufacturing and marketing of cosmetics, prescription medicines and family health products. Pharmaceuticals and phytotherapy represent 47% of turnover, whereas cosmetics represent 53% (percentages of 2012 turnover).
Pierre Fabre is best known for its vinorelbine (Navelbine), an anticancer drug of the vinca alkaloid clas
The Pierre Fabre group has a unique shareholding structure that guarantees its continuity and independence, while perpetuating the humanist values of its founder. The majority shareholder is the Pierre Fabre Foundation, which is a government-recognized public-interest organization. It has also developed its employee stock ownership plan, and employees thus form the second-largest group of shareholders. This structure is unique in France and is aimed at ensuring the long-term stability of the company's capital.
The Pierre Fabre Foundation is the Group’s majority shareholder. A government-recognized public-interest organization, its priority is to carry out its public interest mission, delegating the supervision of the Group’s management to Pierre Fabre Participations.
Pierre Fabre Participations validates the Group’s strategy, appoints its corporate executives and ensures that the continuity mission defined by Mr. Pierre Fabre is carried out.